Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function (Q35745285)

10 August 2017

1 reference

MDMA

0 references

title

Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function (English)

1 reference

10 August 2017

M Isabel Colado

1

1 reference

10 August 2017

Esther O'Shea

series ordinal

2

1 reference

10 August 2017

A Richard Green

series ordinal

3

1 reference

10 August 2017

language of work or name

1 reference

9 April 2004

1 reference

10 August 2017

number of pages

15

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

10 August 2017

volume

173

1 reference

10 August 2017

issue

3-4

1 reference

10 August 2017

page(s)

249-263

1 reference

A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00213-004-1788-8

5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-004-1788-8

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-004-1788-8

Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by L-tryptophan or 5-methoxy-N,N-dimethyltryptamine in rats treated with a monoamine oxidase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-004-1788-8

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-004-1788-8

Dopaminergic mechanisms in idiopathic and drug-induced psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-004-1788-8

Serotonin neurotoxicity after ( /-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-004-1788-8

PET study of competition between intravenous cocaine and [11C]raclopride at dopamine receptors in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-004-1788-8

A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration

21 January 2018

1 reference

12 December 2020

In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain

1 reference

12 December 2020

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

1 reference

12 December 2020

L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats

1 reference

12 December 2020

Restraint as a stressor in mice: against the dopaminergic neurotoxicity of D-MDMA - low body weight mitigates restraint-induced hypothermia and consequent neuroprotection

1 reference

12 December 2020

Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.

1 reference

12 December 2020

Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan

1 reference

12 December 2020

Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain

1 reference

12 December 2020

Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems

1 reference

12 December 2020

Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users

1 reference

12 December 2020

Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.

1 reference

12 December 2020

MDMA: historical perspectives

1 reference

12 December 2020

Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin

1 reference

12 December 2020

Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate

1 reference

12 December 2020

d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity

1 reference

12 December 2020

Distinct morphologic classes of serotonergic axons in primates exhibit differential vulnerability to the psychotropic drug 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

The interaction between the central and peripheral nervous systems in mediating the thermic effect of methamphetamine

1 reference

12 December 2020

5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa

1 reference

12 December 2020

Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites

1 reference

12 December 2020

1 reference

12 December 2020

Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphetamine (Ecstasy).

1 reference

12 December 2020

The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.

1 reference

12 December 2020

Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals

1 reference

12 December 2020

A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

1 reference

12 December 2020

Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate

1 reference

12 December 2020

Lack of serotonin neurotoxicity after intraraphe microinjection of ( )-3,4-methylenedioxymethamphetamine (MDMA)

1 reference

12 December 2020

MDMA induced dopamine release in vivo: role of endogenous serotonin

1 reference

12 December 2020

Serotonergic neurotoxicity of 3,4-( /-)-methylenedioxyamphetamine and 3,4-( /-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase

1 reference

12 December 2020

Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.

1 reference

12 December 2020

The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').

1 reference

12 December 2020

Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice

1 reference

12 December 2020

Methysergide potentiates the hyperactivity produced by MDMA in rats

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

1 reference

12 December 2020

Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum

1 reference

12 December 2020

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

1 reference

12 December 2020

Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes

1 reference

12 December 2020

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy')

1 reference

12 December 2020

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

12 December 2020

Altered serotonin innervation patterns in the forebrain of monkeys treated with ( /-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery

1 reference

12 December 2020

Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor

1 reference

12 December 2020

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

1 reference

12 December 2020

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

12 December 2020

2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of ( /-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations

1 reference

12 December 2020

An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.

1 reference

12 December 2020

Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).

1 reference

12 December 2020

Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats

1 reference

12 December 2020

Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens:

1 reference

12 December 2020

Acute and subchronic effects of methylenedioxymethamphetamine [( /-)MDMA] on locomotion and serotonin syndrome behavior in the rat

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys

1 reference

12 December 2020

Pharmacological studies of the acute effects of ( )-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors

1 reference

12 December 2020

Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.

1 reference

12 December 2020

1 reference

12 December 2020

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

1 reference

12 December 2020

3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans

1 reference

12 December 2020

Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse.

1 reference

12 December 2020

Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine

1 reference

12 December 2020

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

12 December 2020

Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity

1 reference

12 December 2020

Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats

1 reference

12 December 2020

Is frequent dosing with ecstasy a risky business for dopamine-containing neurons?

1 reference

12 December 2020

Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.

1 reference

12 December 2020

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

12 December 2020

Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.

1 reference

12 December 2020

Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

1 reference

12 December 2020

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

1 reference

12 December 2020

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

12 December 2020

Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration

1 reference

12 December 2020

Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?

1 reference

12 December 2020

Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity

1 reference

12 December 2020

Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.

1 reference

12 December 2020

Carrier-dependent and Ca(2 )-dependent 5-HT and dopamine release induced by ( )-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and ( )-fenfluramine.

1 reference

12 December 2020

Metabolism of 5-(glutathion-S-yl)-alpha-methyldopamine following intracerebroventricular administration to male Sprague-Dawley rats

1 reference

12 December 2020

Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA).

1 reference

12 December 2020

Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood

1 reference

12 December 2020

Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement

1 reference

12 December 2020

1 reference

12 December 2020

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals

1 reference

12 December 2020

In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: Identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques

1 reference

12 December 2020

Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine

1 reference

12 December 2020

1 reference

12 December 2020

Molecular genetics of the debrisoquin-sparteine polymorphism

1 reference

12 December 2020

Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst

1 reference

12 December 2020

Enhancement of cocaine-induced hyperthermia fails to elicit neurotoxicity

1 reference

12 December 2020

Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys

1 reference

12 December 2020

SPECT imaging of striatal dopamine release after amphetamine challenge

1 reference

12 December 2020

Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity

1 reference

12 December 2020

Effects of intracerebroventricular administration of 5-(glutathion-S-yl)-alpha-methyldopamine on brain dopamine, serotonin, and norepinephrine concentrations in male Sprague-Dawley rats

1 reference

12 December 2020

Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant ( /-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response.

1 reference

12 December 2020

Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector

1 reference

12 December 2020

Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice

1 reference

12 December 2020

Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo

1 reference

12 December 2020

Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion

1 reference

12 December 2020

An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA

1 reference

12 December 2020

Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.

1 reference

12 December 2020

nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice

1 reference

12 December 2020

Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats

1 reference

12 December 2020

Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.

1 reference

12 December 2020

Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice

1 reference

12 December 2020

Pharmacological studies of the acute and chronic effects of ( )-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.

1 reference

12 December 2020

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects

1 reference

12 December 2020

5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates

1 reference

12 December 2020

Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates

1 reference

12 December 2020

Ion trap tandem mass spectrometric evidence for the metabolism of 3,4-(methylenedioxy)methamphetamine to the potent neurotoxins 2,4,5-trihydroxymethamphetamine and 2,4,5-trihydroxyamphetamine

1 reference

12 December 2020

Retracted article on dopaminergic neurotoxicity of MDMA

1 reference

12 December 2020

CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA).

1 reference

12 December 2020

Altered prolactin response to M-chlorophenylpiperazine in monkeys previously treated with 3,4-methylenedioxymethamphetamine (MDMA) or fenfluramine

1 reference

12 December 2020

Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report

1 reference

12 December 2020

Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug ( /-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")

1 reference

12 December 2020

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

1 reference

12 December 2020

Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse

1 reference

12 December 2020

Neurotoxic amphetamine analogues: effects in monkeys and implications for humans

1 reference

12 December 2020

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

1 reference

12 December 2020

Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats

1 reference

12 December 2020

Major metabolites of(±)3,4-methylenedioxyamphetamine (MDA) do not mediate its toxic effects on brain serotonin neurons

1 reference

12 December 2020

The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole

1 reference

12 December 2020

Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat

1 reference

12 December 2020

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice

1 reference

12 December 2020

More about parkinsonism after taking ecstasy.

1 reference

12 December 2020

Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors

1 reference

12 December 2020

Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?

1 reference

12 December 2020

Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis

1 reference

12 December 2020

Effects of ( /-) 3,4-methylene-dioxymethamphetamine (ecstasy) on dopamine system function in humans

1 reference

12 December 2020

Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration

1 reference

12 December 2020

Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity

1 reference

12 December 2020

Glucocorticoids may alter antioxidant enzyme capacity in the brain: baseline studies

1 reference

12 December 2020

Cognitive performance in ( /-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

1 reference

12 December 2020

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors

1 reference

12 December 2020

Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum

1 reference

12 December 2020

A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain

1 reference

12 December 2020

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

1 reference

12 December 2020

Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations.

1 reference

12 December 2020

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

12 December 2020

Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.

1 reference

12 December 2020

Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice

1 reference

12 December 2020

Chronic treatment with supraphysiological levels of corticosterone enhances d-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse

1 reference

12 December 2020

Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity

1 reference

12 December 2020

Neurotoxicity of MDMA: neurochemical effects

1 reference

12 December 2020

Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs

1 reference

12 December 2020

Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.

1 reference

12 December 2020

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

1 reference

12 December 2020

Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse

1 reference

12 December 2020

Involvement of serotonergic and dopaminergic mechanisms in hyperthermia induced by a serotonin-releasing drug, p-chloroamphetamine in mice

1 reference

12 December 2020

MDMA and Parkinsonism

1 reference

12 December 2020

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites

1 reference

12 December 2020

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

12 December 2020

Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra

1 reference

12 December 2020

Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain

1 reference

12 December 2020

MDMA elicits behavioral and neurochemical sensitization in rats

1 reference

12 December 2020

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

12 December 2020

Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine

1 reference

12 December 2020

Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature

1 reference

12 December 2020

Synthesis and neurotoxicological evaluation of putative metabolites of the serotonergic neurotoxin 2-(methylamino)-1-[3,4-(methylenedioxy)phenyl] propane [(methylenedioxy)methamphetamine]

1 reference

12 December 2020

Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations

1 reference

12 December 2020

Cocaine and cocaethylene: microdialysis comparison of brain drug levels and effects on dopamine and serotonin

1 reference

12 December 2020

The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA).

1 reference

12 December 2020

Pre-exposure to ( /-)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats

1 reference

12 December 2020

Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat.

1 reference

12 December 2020

Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats

1 reference

12 December 2020

Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs

1 reference

12 December 2020

( /-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates

1 reference

12 December 2020

In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine

1 reference

12 December 2020

Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing

1 reference

12 December 2020

10.1007/S00213-004-1788-8

Identifiers

DOI

1 reference

10 August 2017

1 reference